Table 1.
Sociodemographic and baseline variables for analysis for treatment intention (ATI). Italicized P values are significant.
| Characteristics | ATI | |||||||||
|
|
TSTMa (n=35) | TCb (n=34) | CGc (n=35) | Chi-square (df) | Kruskal-Wallis (df) | P value | ||||
| Gender (female), n (%) | 8 (22.86) | 9 (26.47) | 16 (45.71) | 4.866 (2) | N/Ad | .09 | ||||
| Age (years), mean (SD) | 14.7 (2.4) | 13.8 (1.9) | 14.6 (2.4) | N/A | 3.171 (2) | .20 | ||||
| Birthplace (Spain), n (%) | 34 (97.14) | 29 (85.29) | 34 (97.14) | 5.188 (2) | N/A | .08 | ||||
| Adoption, n (%) | 1.992 (4) | N/A | .74 | |||||||
|
|
Adopted | 2 (5.71) | 2 (5.88) | 2 (5.71) |
|
|
|
|||
|
|
Shelter home | 0 (0) | 0 (0) | 1 (2.86) |
|
|
|
|||
| ADHDe diagnosed, n (%) | 1.771 (2) | N/A | .41 | |||||||
|
|
Inattentive | 19 (54.29) | 14 (41.18) | 14 (40) |
|
|
|
|||
|
|
Combined | 16 (45.71) | 20 (58.82) | 21 (60) |
|
|
|
|||
| Medication, n (%) | 17.016 (12) | N/A | .15 | |||||||
|
|
Elvanse | 24 (68.57) | 24 (70.59) | 26 (74.29) |
|
|
|
|||
|
|
Medikinet | 7 (20) | 2 (5.88) | 3 (8.57) |
|
|
|
|||
|
|
Equasym | 3 (8.57) | 1 (2.94) | 2 (5.71) |
|
|
|
|||
|
|
Rubricon | 1 (2.86) | 2 (5.88) | 2 (5.71) |
|
|
|
|||
|
|
Stratera | 0 (0) | 3 (8.82) | 0 (0) |
|
|
|
|||
|
|
Intuniv | 0 (0) | 1 (2.94) | 0 (0) |
|
|
|
|||
|
|
Concerta | 0 (0) | 0 (0) | 2 (5.71) |
|
|
|
|||
aTSTM: The Secret Trail of Moon.
bTC: Therapeutic Chess.
cCG: control group.
dN/A: not applicable.
eADHD: attention-deficit/hyperactivity disorder.